The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implications for the pathogenesis of dialysis-related amyloidosis

Journal of Clinical Investigation

Volumn 98, Issue 5, 1996, Pages 1088-1094

  Miyata, Toshio ^a   Hori, Osamu ^b   Zhang, JingHua ^b   Yan, Shi Du ^b   Ferran, Luis ^b   Iida, Yoshiyasu ^a   Schmidt, Ann Marie ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

amyloidosis; cytokines; glycated proteins; long term hemodialysis patients; monocyte

Indexed keywords

ACETYLCYSTEINE; AMYLOID; BETA 2 MICROGLOBULIN; OXIDIZING AGENT; TUMOR NECROSIS FACTOR ALPHA;

AMYLOIDOSIS; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0029738444     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118889     Document Type: Article

References (38)

1. Ruderman, N., J. Williamson, and M. Brownlee. 1992. Glucose and diabetic vascular disease. FASEB (Fed. Am. Soc. Biol.) J. 6:2905-2914.
2. Baynes, J. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405-412.
3. Sell, D., and V. Monnier. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix: implication of pentoses in the aging process. J. Biol. Chem. 264:21597-21602.
4. Brownlee, M., A. Cerami, and H. Vlassara. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1320.
5. Bucala, R., Z. Makita, T. Koschinsky, A. Cerami, and H. Vlassara. 1993. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA. 90:6434-6438.
6. Hicks, M., L. Delbridge, D. Yue, and R. Reeve. 1988. Catalysis of lipid peroxidation by glucose and glycosylated proteins. Biochem. Biophys. Res. Commun. 151:649-655.
7. Hunt, J., C. Smith, and S. Wolff. 1990. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 30:1420-1424.
8. Palinski, W., T. Koschinsky, S.W. Butler, E. Miller, H. Vlassara, A. Cerami, and J.L. Witztum. 1995. Immunological presence of AGEs in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15:571-582.
9. Smith, M., S. Taneda, P. Richey, S. Miyata, S.D. Yan, D. Stern, V. Monnier, and G. Perry. 1994. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:5710-5714.
10. Yan, S.D., X. Chen, A.M. Schmidt, J. Brett, G. Godman, C. Scott, C. Caputo, T. Frappier, M. Smith, G. Perry, et al. 1994. The presence of glycated tau in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:7787-7791.
11. Yan, S.D., S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M.A. Smith, G. Perry, G.C. Godman, P. Nawroth, et al. 1995. Nonenzymatically-glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cylokine gene expression and release of amyloid-β peptide. Nat. Med. 1:693-699.
12. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J. Clin. Invest. 93:521-528.
13. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 92:1243-1252.
14. Schmidt, A.M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, M. Clauss, et al. 1992. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267:14987-14997.
15. Schmidt, A.M., S.D. Yan, J. Brett, R. Mora, R. Nowygrod, and D. Stern. 1993. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J. Clin. Invest. 92:2155-2168.
16. Yan, S.D., A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, and D. Stern. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol. Chem. 269:9889-9897.
17. Schmidt, A.M., O. Hori, J.X. Chen, J.F. Li, J. Crandall, J.H. Zhang, R. Cao, S.D. Yan, J. Brett, and D. Stern. 1995. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96:1395-1403.
18. Schmidt, A.M., M. Haseu, D. Popov, J.H. Zhang, S.D. Yan, J. Brett, R. Cao, K. Kuwahara, G. Costache, N. Simionescu, et al. 1994. The receptor for advanced glycation endproducts (AGEs) has a central role in vessel wall interaction and gene activation in response to AGEs in the intravascular space. Proc. Natl. Acad. Sci. USA. 91:8807-8811.
19. Neeper, M., A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C. Pan, K. Elliston, D. Stern, and A. Shaw. 1992. Cloning and expression of RAGE: a cell surface receptor for advanced glycation endproducts of proteins. J. Biol. Chem. 267:14998-15004.
20. Baynes, J.W., and V.M. Monnier. 1989. The Maillard reaction in aging, diabetes and nutrition. Prog. Clin. Biol. Res. 304:1-410.
21. Horiuchi, S., N. Araki, and Y. Morino. 1991. Immunochemical approach to characterize advanced glycation endproducts of the Maillard reaction. J. Biol. Chem. 266:7329-7332.
22. David, G.S., and R. Reisfeld. 1974. Protein iodination with solid state lactoperoxidase. Biochemistry. 13:1014-1020.
23. Klotz, I., and D. Hunston. 1984. Mathematical models for ligand-receptor binding. J. Biol. Chem. 258:11442-11445.
24. - generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP. Biochim. Biophys. Acta. 1043:27-33.
25. Yang, Z., Y. Makita, S. Horii, A. Brunelle, A. Cerami, P. Sehajpal, M. Suthanthiran, and H. Viassara. 1991. Two novel rat liver membrane proteins that bind AGEs. Relationship to macrophage receptor for glucose-modified proteins. J. Exp. Med. 174:515-524.
26. Khoury, J., C. Thomas, J. Loike, S. Hickman, L. Cao, and S. Silverstein. 1994. Macrophages adhere to glucose-modified basement membrane via their scavenger receptors. J. Biol. Chem. 269:10197-10200.
27. Brett, J., A.M. Schmidt, S.D. Yan, Y.S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, et al. 1993 Survey of the distribution of a newly characterized receptor for advanced glycation endproducts in tissues. Am. J. Pathol. 143:1699-1712.
28. Wautier, J.-L., C. Zoukourian, O. Chappey, M.-P. Wautier, P.-J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.M. Schmidt. 1996. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 96:238-243.
29. Ritthaler, U., Y. Deng, Y. Zhang, J. Greten, M. Abel, B. Sido, J. Allenberg, G. Otto, H. Roth, A. Bierhaus, et al. 1995. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am. J. Pathol. 146:688-694.
30. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J.X. Chen, M. Nagashima, E.R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation endproducts is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270:25752-25761.
31. Aggeler, J., S.M. Frisch, and Z. Werb. 1984. Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts. J. Cell Biol. 98:1662-1671.
32. Woolley, D.E., E.D. Harris, Jr., C.L. Mainardi, and C.E. Brinckerhoff. 1978. Collagenase immunolocalization in cultures of rheumatoid synovial cells. Science (Wash. DC). 200:773-775.
33. Horowitz, M.C. 1993. Cytokines and estrogen in bone; anti-osteoporotic effects. Science (Wash. DC). 200:626-627.
34. Girasole, G., R.L. Jilka, G. Passeri, S. Boswell, G. Boder, D.C. Williams, and S.C. Manolagas. 1992. β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro. Potential mechanism for the antiosteoporotic effect of estrogen. J. Clin. Invest. 89:883-891.
35. Lowik, C.W.G.M., G. Van der Pluijm, H. Bloys, K. Hoekman, O.L.M. Bijvoet, L.A. Aarden, and S.E. Papapoulos. 1989. Parathyroid hormone (PTH) and PTH-like protein stimulate IL-6 production by osteogenic cells: a possible role of IL-6 in osteoclastogenesis. Biochem. Biophys. Res. Commun. 162:1546-1552.
36. 2microglobulin amyloidosis and renal bone disease. Miner. Electrolyte Metab. 17:261-272.
37. Koch, K.M. 1992. Dialysis-related amyloidosis. Kidney Int. 41:1416-1429.
38. Hynes, R.O. 1992. Integrins: versatility, modulation and signalling in cell adhesion. Cell. 69:11-25.